[{"Assets_0_Q2_USD":12278090000.0,"CommonStockSharesOutstanding_0_Q2_shares":223284141.0,"EarningsPerShareBasic_1_Q2_USD":-6.26,"EarningsPerShareBasic_2_Q2_USD":-7.04,"EarningsPerShareDiluted_1_Q2_USD":-6.26,"EarningsPerShareDiluted_2_Q2_USD":-7.04,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":340986000.0,"NetIncomeLoss_1_Q2_USD":-1396518000.0,"NetIncomeLoss_2_Q2_USD":-1570346000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":223158000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":223086000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":223158000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":223086000.0,"Ticker":"ENDP","CIK":"1593034","name":"ENDO INTERNATIONAL PLC","OfficialName":"Endo International plc Ordinary Shares","form":"10-Q","period":"20170630","fy":"2017.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"640358301.0","Country":"Ireland","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20170808"}]